Understand the source comparison
Bioavailability: Liposomal vs Reduced vs Acetyl-Glutathione
Glutathione bioavailability varies dramatically by formulation. Standard reduced L-glutathione capsules face the hepatic first-pass issue described earlier. Liposomal glutathione. Glutathione encapsulated in phospholipid vesicles. Bypasses some hepatic metabol
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Glutathione bioavailability varies dramatically by formulation. Standard reduced L-glutathione capsules face the hepatic first-pass issue described earlier. Liposomal glutathione. Glutathione encapsulated in phospholipid vesicles. Bypasses some hepatic metabolism by absorbing through intestinal lymphatic channels instead of the hepatic portal vein, increasing systemic bioavailability by 30–50% compared to standard capsules. S-acetyl-glutathione, a form where the sulfhydryl group is acetylated, resists breakdown in the stomach and small intestine, allowing more intact glutathione to reach enterocytes before absorption.
- The trade-off is cost and stability. Liposomal glutathione is 3–5× more expensive than standard reduced glutathione and requires refrigeration to prevent phospholipid oxidation. S-acetyl-glutathione is stable at room temperature but costs 2–3× more than standard forms. For most protocols targeting skin radiance, standard reduced L-glutathione dosed at 500–1000mg daily with cofactor support (vitamin C 1000–2000mg, NAC 600–1200mg) produces equivalent results to lower-dose liposomal formulations at a fraction of the cost.
- Research from Real Peptides into peptide bioavailability has consistently shown that delivery form matters less than systemic cofactor support when the goal is sustained elevation of active compounds in circulation. The same principle applies to glutathione: hepatic recycling capacity determines systemic GSH levels more than absorption efficiency alone.